| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000203362.2 |
Vismodegib |
Pancreatic adenocarcinoma |
0.049656672 |
Resistant |
| ENSG00000203362.2 |
Vismodegib |
Breast invasive carcinoma |
0.00887872 |
Sensitive |
| ENSG00000203362.2 |
Vismodegib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015323446 |
Sensitive |
